Food Hypersensitivity
44
4
4
32
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
13 trials with published results (30%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.3%
1 terminated out of 44 trials
97.0%
+10.5% vs benchmark
0%
0 trials in Phase 3/4
41%
13 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (44)
Oral Immunotherapy in Food Allergy in Finland
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Recombinant Tropomyosin- and Hemocyanin-Specific IgE in Children With Suspected Shrimp Allergy
SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)
Validation of Turkish Versions Child- and Parent-Rated Scales of Food Allergy Anxiety
A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
A Registry for the Food Allergy Community
Traditional Asian Diet and Gut Microbiome and Metabolome in Healthy Volunteers and Pregnancy on Infant's Allergy Development
Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity
Do Patients With Fish or Shellfish Allergy Tolerate the Consumption of Fish Oil Supplements? A Clinical Study
Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder
Hydroponic Cultivation in Systemic Nickel Allergy Syndrome
FARE Peanut SLIT and Early Tolerance Induction
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
Mechanisms Underlying Peanut Allergic Reactions in TRACE Peanut Study Participants: Extension Study
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Impact of Vaccination on Th2 Immunity in Infancy
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial